Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0074 | 0.0603 | 0.0766 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0259 | 0.0238 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.5 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0022 | 0.0028 |
Trypanosoma brucei | N-myristoyltransferase | 0.0754 | 0.7873 | 1 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0754 | 0.7873 | 1 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0092 | 0.0791 | 0.1004 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0024 | 0.0067 | 0.0057 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0754 | 0.7873 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.002 | 0.0022 | 0.0028 |
Leishmania major | N-myristoyl transferase, putative | 0.0754 | 0.7873 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0067 | 0.0085 |
Schistosoma mansoni | zinc finger protein | 0.0023 | 0.0054 | 0.0068 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0091 | 0.0069 |
Brugia malayi | Bromodomain containing protein | 0.0088 | 0.075 | 0.0812 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.003 | 0.001 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.014 | 0.1308 | 0.1638 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0022 | 0.0028 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0754 | 0.7873 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.006 | 0.0452 | 0.4744 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.006 | 0.0452 | 0.0431 |
Brugia malayi | Muscleblind-like protein | 0.0176 | 0.1685 | 0.2018 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0091 | 0.0088 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.0834 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0754 | 0.7873 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0092 | 0.0791 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0045 | 0.0289 | 0.0217 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.002 | 0.0022 | 0.0028 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0176 | 0.1685 | 0.1667 |
Brugia malayi | MH2 domain containing protein | 0.014 | 0.1308 | 0.1532 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.0791 | 0.0979 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.0697 | 0.0859 |
Echinococcus multilocularis | muscleblind protein | 0.0176 | 0.1685 | 0.1667 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0092 | 0.0791 | 1 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.006 | 0.0452 | 0.5 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0754 | 0.7873 | 0.7869 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0092 | 0.0791 | 0.0834 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.1685 | 0.2118 |
Echinococcus granulosus | muscleblind protein | 0.0176 | 0.1685 | 0.2118 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0344 | 0.041 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.077 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0754 | 0.7873 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.032 | 0.0379 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.0979 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.029 | 0.0341 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.006 | 0.0452 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0259 | 0.0302 |
Giardia lamblia | CDC72 | 0.0754 | 0.7873 | 0.5 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0754 | 0.7873 | 1 |
Echinococcus granulosus | zinc finger protein | 0.0023 | 0.0054 | 0.004 |
Schistosoma mansoni | N-myristoyltransferase | 0.0754 | 0.7873 | 1 |
Echinococcus granulosus | peptidase Clp S14 family | 0.006 | 0.0452 | 0.0548 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0754 | 0.7873 | 0.5 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0754 | 0.7873 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.1685 | 0.2118 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.007 | 0.0558 | 0.0683 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.5 |
Brugia malayi | N-myristoyltransferase 2 | 0.0754 | 0.7873 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.0023 | 0.0054 | 0.0032 |
Brugia malayi | Probable ClpP-like protease | 0.0092 | 0.0791 | 0.0864 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0091 | 0.0116 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0092 | 0.0791 | 0.5 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0754 | 0.7873 | 1 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0092 | 0.0791 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.014 | 0.1308 | 0.1638 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.007 | 0.0558 | 0.0537 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.